STOCK TITAN

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Cardlytics (NASDAQ: CDLX) has announced the granting of 225,800 restricted stock units to 18 newly hired employees as employment inducements. The grants, approved by the Compensation Committee of Cardlytics' Board of Directors on February 26, 2025, comply with Nasdaq Listing Rule 5635(c)(4) and were issued under the company's 2022 Inducement Plan.

The vesting schedule stipulates that 50% of the restricted stock units will vest on the first anniversary of the grant date, with the remaining 50% vesting quarterly over the subsequent 12 months, contingent upon continuous employment with Cardlytics.

Cardlytics (NASDAQ: CDLX) ha annunciato l'assegnazione di 225.800 unità azionarie vincolate a 18 nuovi dipendenti come incentivo all'assunzione. Le assegnazioni, approvate dal Comitato per la Compensazione del Consiglio di Amministrazione di Cardlytics il 26 febbraio 2025, sono conformi alla Regola di Quotazione Nasdaq 5635(c)(4) e sono state emesse nell'ambito del Piano di Incentivazione 2022 dell'azienda.

Il piano di maturazione prevede che il 50% delle unità azionarie vincolate maturerà al primo anniversario della data di assegnazione, con il restante 50% che maturerà trimestralmente nei successivi 12 mesi, a condizione di un impiego continuativo presso Cardlytics.

Cardlytics (NASDAQ: CDLX) ha anunciado la concesión de 225,800 unidades de acciones restringidas a 18 nuevos empleados como incentivos de empleo. Las concesiones, aprobadas por el Comité de Compensación de la Junta Directiva de Cardlytics el 26 de febrero de 2025, cumplen con la Regla de Listado de Nasdaq 5635(c)(4) y se emitieron bajo el Plan de Incentivos 2022 de la empresa.

El calendario de adquisición estipula que el 50% de las unidades de acciones restringidas se adquirirán en el primer aniversario de la fecha de concesión, con el restante 50% adquiriéndose trimestralmente durante los siguientes 12 meses, condicionado a la continuidad del empleo en Cardlytics.

Cardlytics (NASDAQ: CDLX)는 18명의 신규 채용 직원에게 225,800개의 제한 주식 단위를 고용 유인으로 부여한다고 발표했습니다. 이 부여는 2025년 2월 26일 Cardlytics 이사회 보상 위원회에서 승인되었으며, Nasdaq 상장 규칙 5635(c)(4)에 부합하며 회사의 2022 유인 계획에 따라 발행되었습니다.

주식 단위의 취득 일정은 50%가 부여일의 첫 번째 기념일에 취득되고, 나머지 50%는 이후 12개월 동안 분기별로 취득되며, Cardlytics에 계속 고용되어 있는 조건입니다.

Cardlytics (NASDAQ: CDLX) a annoncé l'octroi de 225 800 unités d'actions restreintes à 18 nouveaux employés comme incitatifs à l'embauche. Les attributions, approuvées par le Comité de Rémunération du Conseil d'Administration de Cardlytics le 26 février 2025, sont conformes à la Règle de Cotation Nasdaq 5635(c)(4) et ont été émises dans le cadre du Plan d'Incitation 2022 de l'entreprise.

Le calendrier d'acquisition stipule que 50% des unités d'actions restreintes seront acquises à la première anniversaire de la date d'octroi, le reste 50% étant acquis trimestriellement au cours des 12 mois suivants, sous réserve d'un emploi continu chez Cardlytics.

Cardlytics (NASDAQ: CDLX) hat die Gewährung von 225.800 eingeschränkten Aktieneinheiten an 18 neu eingestellte Mitarbeiter als Anreiz zur Beschäftigung angekündigt. Die Gewährungen, die am 26. Februar 2025 vom Vergütungsausschuss des Vorstands von Cardlytics genehmigt wurden, entsprechen der Nasdaq-Listing-Regel 5635(c)(4) und wurden im Rahmen des Unternehmensplans zur Anwerbung von 2022 ausgegeben.

Der Vesting-Zeitplan sieht vor, dass 50% der eingeschränkten Aktieneinheiten am ersten Jahrestag des Gewährungsdatums fällig werden, während die verbleibenden 50% vierteljährlich über die folgenden 12 Monate fällig werden, vorausgesetzt, dass die Beschäftigung bei Cardlytics fortgesetzt wird.

Positive
  • Successful recruitment of 18 new employees
  • Implementation of employee retention strategy through equity compensation
Negative
  • Potential dilution of existing shareholders from 225,800 new stock units

ATLANTA--(BUSINESS WIRE)-- Cardlytics, Inc. (NASDAQ: CDLX) today announced that on February 26, 2025, the Compensation Committee of Cardlytics’ Board of Directors granted an aggregate of 225,800 restricted stock units of Cardlytics to 18 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”).

For all of the grant recipients, 50% of the restricted stock units shall vest on the first anniversary of the grant date, and the remaining 50% shall vest quarterly over the subsequent 12 months, subject to the employees’ continuous service with Cardlytics through the vesting date. The restricted stock units are subject to the terms and conditions of the 2022 Inducement Plan.

About Cardlytics

Cardlytics (NASDAQ: CDLX) is a digital advertising platform. We partner with financial institutions to run their rewards programs that promote customer loyalty and deepen relationships. In turn, we have a secure view into approximately 1 of every 2 card-based transactions in the U.S., allowing us to see where and when consumers are spending their money. We use these insights to help marketers identify, reach, and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in Menlo Park, Los Angeles, New York, and London. Learn more at www.cardlytics.com.

Public Relations:

pr@cardlytics.com

Investor Relations:

ir@cardlytics.com

Source: Cardlytics, Inc.

FAQ

How many restricted stock units did Cardlytics (CDLX) grant in February 2025?

Cardlytics granted 225,800 restricted stock units to 18 new employees.

What is the vesting schedule for Cardlytics (CDLX) February 2025 inducement grants?

50% vests after one year, remaining 50% vests quarterly over the following 12 months.

How many new employees received CDLX restricted stock units in February 2025?

18 newly hired employees received the restricted stock units.

Under which plan were the CDLX February 2025 inducement grants issued?

The grants were issued under the Cardlytics 2022 Inducement Plan.

Cardlytics

NASDAQ:CDLX

CDLX Rankings

CDLX Latest News

CDLX Stock Data

127.06M
47.91M
5.27%
58.79%
15.47%
Advertising Agencies
Services-computer Programming, Data Processing, Etc.
Link
United States
ATLANTA